A Common Mechanism of Inhibition of the Mycobacterium tuberculosis Mycolic Acid Biosynthetic Pathway by Isoxyl and Thiacetazone (original) (raw)
Biochemical Characterization of Isoniazid-resistant Mycobacterium tuberculosis: Can the Analysis of Clonal Strains Reveal Novel Targetable Pathways?
Luisa Nieto
Molecular & Cellular Proteomics, 2018
View PDFchevron_right
Drugs that Inhibit Mycolic Acid Biosynthesis in Mycobacterium tuberculosis
Osmar Norberto de Souza
Current Pharmaceutical Biotechnology, 2002
View PDFchevron_right
Mycothiol biosynthesis is essential for ethionamide susceptibility in Mycobacterium tuberculosis
Bing Chen
Molecular Microbiology, 2008
View PDFchevron_right
Mechanisms and Action of Drug Resistance on Mycobacterium tuberculosis
muthuraj muthaiah
Antibiotic Resistance - New Insights [Working Title]
View PDFchevron_right
Drug Resistance Mechanisms in Mycobacterium tuberculosis
juan andres palomino
Antibiotics, 2014
View PDFchevron_right
Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs
Pedro Almeida da Silva
Journal of Antimicrobial Chemotherapy, 2011
View PDFchevron_right
Expression and characterization of Rv0447c product, potentially the methyltransferase involved in tuberculostearic acid biosynthesis inMycobacterium tuberculosis
Laxman R Meena
Biotechnology and Applied Biochemistry, 2013
View PDFchevron_right
Determination of Efficacy of Isoxyl, a Mycolic Acid Inhibitor, in Vitro Against MYCOBACTERIUM.TUBERCULOSIS Strains
Abhay Chowdhary
LIFE: International Journal of Health and Life-Sciences, 2015
View PDFchevron_right
Multidrug-Resistant Mycobacterium tuberculosis: Molecular Perspectives
Dr Ashok Rattan
Emerging Infectious Diseases, 1998
View PDFchevron_right
Genomic and functional analyses of Mycobacterium tuberculosis strains implicate ald in d-cycloserine resistance
Alex Pym
View PDFchevron_right
Binding Pocket Alterations in Dihydrofolate Synthase Confer Resistance to para-Aminosalicylic Acid in Clinical Isolates of Mycobacterium tuberculosis
Breanna Turman
Antimicrobial Agents and Chemotherapy, 2014
View PDFchevron_right
The Mycobacterium Tuberculosis FAS-II Dehydratases and Methyltransferases Define the Specificity of the Mycolic Acid Elongation Complexes
Didier Zerbib
View PDFchevron_right
Determining the Efficacy of Isoxyl, a Mycolic Acid Inhibitor, in Vitro Against Mycobacteria Other Than Mycobacterium Tuberculosis (Mott) Strains
Haffkine Clinical Pathology
LIFE: International Journal of Health and Life-Sciences
View PDFchevron_right
124-PA11 Rapid drug susceptibility testing of Mycobacterium tuberculosis by a microdilution broth minimum inhibitory concentration (MIC) method
Maria Telles
Tubercle and Lung Disease, 1995
View PDFchevron_right
Perspectives Multidrug-Resistant Mycobacterium tuberculosis: Molecular Perspectives
Ashok Rattan
2013
View PDFchevron_right
Mycobacterial Metabolic Pathways as Drug Targets: A Review
Jemal Adem
View PDFchevron_right
Drug Resistance in Mycobacterium tuberculosis
Rabia Johnson
Antimicrobial Resistance in Developing Countries, 2009
View PDFchevron_right
Overview on the Phenotypic Drug Resistance in Mycobacterium Tuberculosis
Sultan A Neja
International Journal of Research Studies in Microbiology and Biotechnology (IJRSMB), 2020
View PDFchevron_right
Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis
Magali Leon
Antimicrobial Agents and Chemotherapy, 2006
View PDFchevron_right
Metabolic Changes of Mycobacterium tuberculosis during the Anti-Tuberculosis Therapy
Julia Bespyatykh
Pathogens, 2020
View PDFchevron_right
Deciphering the sequential events during in vivo acquisition of drug resistance in Mycobacterium tuberculosis
Amit Singh
View PDFchevron_right
Deregulation of Genes Associated with Alternate Drug Resistance Mechanisms in Mycobacterium tuberculosis
Kayzad Nilgiriwala
Current Microbiology, 2017
View PDFchevron_right
Mycobacterium tuberculosis Lacking All Mycolic Acid Cyclopropanation Is Viable but Highly Attenuated and Hyperinflammatory in Mice
Kris Huygen
Infection and Immunity, 2012
View PDFchevron_right
Review on Molecular Mechanism of First Line Antibiotic Resistance in Mycobacterium tuberculosis
Debasu Damtie, Desalegn Woldeyohannes
View PDFchevron_right
The missing piece of the type II fatty acid synthase system from Mycobacterium tuberculosis
Tanya Parish
Proceedings of the National Academy of Sciences, 2007
View PDFchevron_right
Methionine Sulfoximine Resistance in Mycobacterium tuberculosis Is Due to a Single Nucleotide Deletion Resulting in Increased Expression of the Major Glutamine Synthetase, GlnA1
Tanya Parish
Microbial Drug Resistance, 2011
View PDFchevron_right
Generation and characterization of thiol-deficient Mycobacterium tuberculosis mutants
C. Carolis
Scientific Data
View PDFchevron_right
Effect of Mutation and Genetic Background on Drug Resistance in Mycobacterium tuberculosis
Ekkehardt Altpeter
Antimicrobial Agents and Chemotherapy, 2012
View PDFchevron_right
Mycobacterium tuberculosis persistence mutants identified by screening in isoniazid-treated mice
John McKinney
Proceedings of the National Academy of Sciences, 2010
View PDFchevron_right